Menstrual-related fluctuations in Parkinson's disease
β Scribed by Dr. Niall P. Quinn; C. David Marsden
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 181 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
There are some confusing details in the recent Annals article by the Parkinson Study Group (PSG), concerning the use of entacapone.'
Loss of dopamine neurons in Parkinson's disease (PD) initiates a complex stream of effects that results in the development of tremor, bradykinesia, and rigidity. While levodopa remains the most effective drug for the symptomatic treatment of PD, its chronic administration is associated with the deve
We read with interest the abstract by Olson et al. (I). They showed that gabapentin improves rigidity, bradykinesia, and tremor in parkinsonism and Parkinson's disease (PD). We administered gabapentin, 900 mg per day, in an open trial to seven nondemented patients with PD who had painful dystonia,